24
B. Paulsson et al. / Mutation Research 535 (2003) 15–24
Thesis, Department of Radiobiology, Stockholm University,
[4] D. Segerbäck, C.-J. Calleman, J.L. Schroeder, L.G.
Costa, E.M. Faustman, Formation of N-7-(2-carbamoyl-2-hy-
droxyethyl)guanine in DNA of the mouse and the rat
following intraperitoneal administration of [14C]acrylamide,
Carcinogenesis 16 (1995) 1161–1165.
Stockholm, 1992.
[17] P. Rydberg, B. Lüning, C.A. Wachtmeister, L. Eriksson, M.
Törnqvist, Applicability of a modified Edman procedure for
measurement of protein adducts: mechanisms of formation
and degradation of phenylthiohydantoins, Chem. Res. Toxicol.
15 (2002) 570–581. 2002.
[18] M. Törnqvist, C. Fred, J. Haglund, H. Helleberg, B. Paulsson,
P. Rydberg, Protein adducts: quantitative and qualitative
aspects of their formation, analysis and applications, J.
Chromatogr. B 778 (2002) 279–308.
[19] J. Mowrer, M. Törnqvist, S. Jensen, L. Ehrenberg, Modified
Edman degradation applied to hemoglobin for monitoring
occupational exposure to alkylating agents, Toxicol. Environ.
Chem. 11 (1986) 215–231.
[20] M. Törnqvist, J. Mowrer, S. Jensen, L. Ehrenberg, Monitoring
of environmental cancer initiators through hemoglobin
adducts by a modified Edman degradation method, Anal. Bio-
chem. 154 (1986) 255–266.
[21] E. Bergmark, Hemoglobin adducts of acrylamide and acrylo-
nitrile in laboratory workers, smokers, and nonsmokers,
Chem. Res. Toxicol. 10 (1997) 78–84.
[22] J. Grawé, L. Abramsson-Zetterberg, G. Zetterberg, Low dose
effects of chemicals as assessed by the flow cytometric in
vivo micronucleus assay, Mutat. Res. 405 (1998) 199–208.
[23] SAS/STAT User’s Guide, Version 6, 4th ed., vol. 2, SAS
Institute Inc., Cary, NC, 1989.
[24] G.B. Payne, P.H. Williams, Reactions of hydrogen peroxide.
VI. Alkaline epoxidation of acrylonitrile, J. Org. Chem. 26
(1961) 651–695.
[25] S. Sugiyama, S. Ohigashi, R. Sawa, H. Hayashi, Selective
preparation of 2,3-epoxypropanamide and its facile conversion
to 2,3-dihydroxypropanamide with acidic resins, Bull. Chem.
Soc. Jpn. 62 (1989) 3202–3206.
[5] B. Paulsson, F. Granath, J. Grawé, L. Ehrenberg, M.
Törnqvist, The multiplicative model for cancer risk assess-
ment: applicability to acrylamide, Carcinogenesis 22 (2001)
817–819.
[6] M. Törnqvist, E. Bergmark, L. Ehrenberg, F. Granath,
Risk assessment of acrylamide, Report PM 7-98 National
Chemicals Inspectorate, Solna, Sweden, 1998 (in Swedish).
[7] S.C.J. Sumner, L. Selvaraj, S.K. Nauhaus, T.R. Fennell,
Urinary metabolites from F344 rats and B6C3F1 mice
coadministered acrylamide and acrylonitrile for 1 or 5 days,
Chem. Res. Toxicol. 10 (1997) 1152–1160.
[8] B. Paulsson, J. Grawé, M. Törnqvist, Hemoglobin adducts and
micronucleus frequencies in mouse and rat after acrylamide
or N-methylolacrylamide treatment, Mutat. Res. 516 (2002)
101–111.
[9] F. Granath, C. Vaca, L. Ehrenberg, M. Törnqvist, Cancer risk
estimation of genotoxic chemicals based on target dose and
a multiplicative model, Risk Anal. 19 (1999) 309–319.
[10] L. Ehrenberg, E. Moustacchi, S. Osterman-Golkar, G. Ekman,
Dosimetry of genotoxic agents and dose–response relation-
ships of their effects, Mutat. Res. 123 (1983) 121–182.
[11] H. Helleberg, H. Xu, L. Ehrenberg, K. Hemminki, U. Rannug,
M. Törnqvist, Studies of dose distribution, premutagenic
events and mutation frequencies for benzo[a]pyrene aiming
at low dose cancer risk estimation, Mutagenesis 16 (2001)
333–337.
[12] M. Törnqvist, Epoxide adducts to N-terminal valine of
hemoglobin, in: J. Everse, K.D. Vandegriff, R.W. Winslow
(Eds.), Methods Enzymol, 1994, pp. 650–657.
[13] C. Bleasdale, B.T. Golding, S.L. Kitson, Preparation of
ethenyl and oxiranol carbamates and their (2-2H2)-derivatives
using selenium chemistry; thermolysis of oxiranol carbamate
and reaction with adenosine, Bioorg. Med. Chem. Lett. 4
(1994) 291–296.
[14] L. Abramsson-Zetterberg, J. Grawé, G. Zetterberg, Erythro-
poiesis and the induction of micronuclei in mouse spleen
determined by flow cytometry, Mutat. Res. 394 (1997) 17–28.
[15] L. Abramsson-Zetterberg, J. Grawé, G. Zetterberg, The
micronucleus test in rat erythrocytes from bone marrow,
spleen and blood: the response to low doses of ionising
radiation, cyclophosphamide and vincristine determined by
flow cytometry, Mutat. Res. 423 (1999) 113–124.
[26] G. Zetterberg, J. Grawé, Flow cytometric analysis of micro-
nucleus induction in mouse erythrocytes by gamma-irradia-
tion at very low dose-rates, Int. J. Radiat. Biol. 64 (1993)
555–564.
[27] J. Grawé, G. Zetterberg, H. Amneus, Effects of extended
low-dose rate exposure to 137Cs detected by flow-cytometric
enumeration of micronucleated erythrocytes in mouse peri-
pheral blood, Int. J. Radiat. Biol. 63 (1993) 339–347.
[28] L. Abramsson-Zetterberg, J. Grawé, G. Zetterberg, Sponta-
neous and radiation-induced micronuclei in erythrocytes from
four species of wild rodents: a comparison with CBA mice,
Mutat. Res. 393 (1997) 55–71.
[29] J. Park, L.M. Kamendulis, M.A. Friedman, J.E. Klaunig,
Acrylamide-induced cellular transformation, Toxicol. Sci. 65
(2002) 177–183.
[16] E. Bergmark, Hemoglobin dosimetry and comparative toxi-
city of acrylamide and its metabolite glycidamide, Ph.D.